Overview
Dr. Cohen is Director of Pediatric Neuro-Oncology and Clinical Director of the Division of Pediatric Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He received his undergraduate degree at Brown University and earned his MD at the Upstate Medical University, in Syracuse, NY. He did his general Pediatric Residency and Chief Residency at the University of Colorado and completed his Pediatric Hematology/Oncology Fellowship at Johns Hopkins. He has served on the faculty since 1994. His research centers on clinical trials of novel therapeutics for children with brain tumors. Dr. Cohen is co-chair of the High-Grade Glioma committee for the Children's Oncology Group and in that capacity has a particular research interest in the development of therapeutics for the treatment of infiltrating gliomas. He serves on the scientific advisory board for a number of organizations including St. Baldricks and the Childhood Brain Tumor Foundation. He is on the editorial board for PDQ with responsibility for authorship of the pediatric CNS brain tumor summaries. The Pediatric Neuro-Oncology program conducts a broad range of research centered primarily around the development and testing of novel therapeutics for children with brain tumors. The multidisciplinary nature of this work translates into continual collaboration with specialists in pediatric neurosurgery, radiation oncology, neuropathology, neuroradiology, neurology, neuro-ophthalmology, neuropsychology, and other related disciplines.
Dr. Cohen is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Glioma, Brain Stem Cancer, Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 62 peer reviewed articles and participating in 41 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
1800 Orleans Street, Bloomberg 11N, Bloomberg 11N, Baltimore, MD 21287
Additional Areas of Focus
Dr. Cohen has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
40 Clinical Trials
Peter Aplan is a Pediatrics specialist and a Pediatric Hematologist Oncology provider in Bethesda, Maryland. Dr. Aplan is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), and Adult T-Cell Leukemia.
Johns Hopkins Children's Center
Dr. Stacy Cooper is the Director of the Pediatric Hematologic Malignancy Program, Director of the Pediatric Hematology/Oncology Fellowship Program, and Clinical Director of the Pediatric Oncology Inpatient Program at the Johns Hopkins School of Medicine. Dr. Cooper received her undergraduate degree in Biology and Spanish at the University of Notre Dame. She earned her M.D. at SUNY Upstate Medical University. She completed her general pediatric residency and chief residency at the Johns Hopkins School of Medicine. She completed her pediatric hematology-oncology fellowship with the Johns Hopkins-National Institutes of Health. Dr. Cooper joined the Johns Hopkins faculty in 2015. Her research focuses on clinical research in acute lymphoblastic leukemia, as well as medical education scholarship related to fellowship training. Dr. Cooper is a member of the American Board of Pediatrics, the American Society of Hematology, the American Society of Pediatric Hematology Oncology and the Association of Pediatric Program Directors. Dr. Cooper is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), and Leukemia.
Johns Hopkins Children's Center
Yang Ding is a Pediatrics specialist and a Pediatric Hematologist Oncology provider in Baltimore, Maryland. Dr. Ding is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Neuroblastoma, and Langerhans Cell Histiocytosis.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Brain Stem CancerDr. Cohen isDistinguished. Learn about Brain Stem Cancer.
- GliomaDr. Cohen isDistinguished. Learn about Glioma.
- MedulloblastomaDr. Cohen isDistinguished. Learn about Medulloblastoma.
- Advanced
- Denys-Drash Syndrome (DDS)Dr. Cohen isAdvanced. Learn about Denys-Drash Syndrome (DDS).
- Diffuse Midline Glioma H3 K27M-Mutant
- Embryonal Tumor with Multilayered Rosettes
- Ewing SarcomaDr. Cohen isAdvanced. Learn about Ewing Sarcoma.
- GangliogliomaDr. Cohen isAdvanced. Learn about Ganglioglioma.
- HepatoblastomaDr. Cohen isAdvanced. Learn about Hepatoblastoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Cohen isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bone Marrow AspirationDr. Cohen isExperienced. Learn about Bone Marrow Aspiration.
- Infantile NeutropeniaDr. Cohen isExperienced. Learn about Infantile Neutropenia.
- NeuroblastomaDr. Cohen isExperienced. Learn about Neuroblastoma.
- NeurofibromatosisDr. Cohen isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Dr. Cohen isExperienced. Learn about Neurofibromatosis Type 1 (NF1).